Kolexia
Kestemont Philippe Oto-rhino-laryngologie
Kestemont Philippe
Oto-rhino-laryngologie
Clinique Saint George
Nice, France
158 Activités
3.1 K Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sensation de froid Cadavre Maladies des poissons Résistance à la maladie Prise de poids Syndrome de perfusion du propofol Embolie Obstruction nasale Infections bactériennes à Gram négatif

Collaborateurs

Voir plus
Ascher Benjamin
Ascher Benjamin
Clinique Sainte Genevieve, Paris, France
Winter Cecile
Winter Cecile
Clinique Saint George, Nice, France
Bodokh Isaac
Bodokh Isaac
Cabinet libéral, Cannes, France
Converset Viethel Sophie
Converset Viethel Sophie
Cabinet libéral, Lyon, France

Industries

Voir plus
Galderma
88 collaboration(s)
Dernière en 2023
Allergan
8 collaboration(s)
Dernière en 2022
Ipsen
4 collaboration(s)
Dernière en 2022
Abbvie
4 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
International Consensus Recommendations on the Aesthetic Usage of Ready to Use Abobotulinumtoxina (Alluzience).
Aesthetic surgery journal   25 juillet 2023
SAMCEP Society consensus on the treatment of upper facial lines with botulinum neurotoxin type A: A tailored approach.
Journal of cosmetic dermatology   05 juillet 2023
Long-term efficacy and safety of a hyaluronic acid dermal filler based on Tri-Hyal technology on restoration of midface volume.
Journal of cosmetic dermatology   02 mai 2023
Liquid AbobotulinumtoxinA: Pooled Data From Two Double-Blind, Randomized, Placebo-Controlled Phase III Studies of Glabellar Line Treatment.
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]   07 octobre 2022
Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines: Phase III, Randomised, Double Blind, Placebo Controlled and Open Label Phase Multicentre Study to Investigate the Efficacy and Safety of BTX-A-HAC NG in the Treatment of Moderate to Severe Glabellar Lines, and Assess the Long Term Efficacy and Safety of BTX-A-HAC NG Following Repeated Treatments in This Indication
Essai Clinique (Ipsen)   15 septembre 2022
BTX-A-HAC NG: A Phase III, Double Blind, Randomised, Placebo Controlled Study To Assess The Efficacy And Safety Of A Single Treatment Of Clostridium Botulinum Toxin Type A To Improve The Appearance Of Moderate To Severe Glabellar Lines
Essai Clinique (Ipsen)   15 septembre 2022
Comparative clinical study for the efficacy and safety of two different hyaluronic acid-based fillers with Tri-Hyal versus Vycross technology: A long-term prospective randomized clinical trial.
Journal of cosmetic dermatology   19 juillet 2022
Zoom sur le programme de la 12ème éditions du ... - Facebook
Facebook   01 juillet 2022
Liquid Spreader Grafts: Internal Nasal Valve Opening with Hyaluronic Acid.
Aesthetic plastic surgery   17 mai 2022
Botulinum toxin type A for the treatment of excessive gingival display - A systematic review.
Journal of stomatology, oral and maxillofacial surgery   14 mai 2022